Daewoong Pharmaceutical Co., Ltd (KRX:069620)
South Korea
· Delayed Price · Currency is KRW 143,300
-1,100 (-0.76%)
At close: Jun 27, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Pharmaceutical | 1,458.09B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | 3.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | 38.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | 62.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -81.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 22.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 7.19B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -12.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -81.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 22.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Consolidated Adjustment | -81.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 22.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 1,251.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 1.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 252.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 19.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment | -81.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidated Adjustment Growth | 22.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|